82
SCHENK, R. et al. Quantitative morphometric evaluation of the inhibitory activity of new
aminobisphosphonates on bone resorption in the rat. Calcificied Tissue International, New
York, v. 38, n. 6, p. 342-349, June 1986.
SCHMUTZ, J. L.; BARBAUD, A.; TRECHOT, P. Alendronate and mouth ulcers: careful
interrogation of the patient to start with. Annales de Dermatologie et de Vénéréologie, Paris,
v. 132, n. 11 pt.1, p. 930, Nov. 2005.
SCHWARTZ, H. C. Osteonecrosis of the jaws: A complication of cancer chemotherapy.
Head Neck& Surgery, New York, v. 4, n. 3, p. 251-253, Jan./Feb. 1982.
SHWEIKI, D. et al. Vascular endothelial growth factor induced by hypoxia may mediate
hypoxia-initiated angiogenesis. Nature, Basingstoke, v. 359, n. 6398, p. 843-845, Oct. 1992.
SIVAKUMAR, B.; HARRY, L. E.; PALEOLOG, E. M. Modulação da angiogênese: mais vs.
menos. The Journal of the American Medical Association, Chicago, v. 3, n. 1, p. 41-47,
Jan. 2004.
SUZUKI, K. et al. Current topics in pharmacological research on bone metabolism: inhibitory
effects of bisphosphonates on the differentiation and activity of osteoclasts. Journal of
Pharmacology Sciences, Tokyo, v. 100, n. 3, p. 189-194, Mar. 2006.
TARASSOFF, P.; CSERMAK, K. Avascular necrosis of the jaws: risk factors in metastatic
cancer patients. Journal of Oral and Maxillofacial Surgery, Philadelphia, v. 61, n. 10, p.
1115-1117, Oct. 2003.
TENENBAUM, H. C. et al. Bisphosphonates and periodontics: potential applications for
regulation of bone mass in the periodontium and other therapeutic/diagnosis uses. Journal of
Periodontology, Chicago, v. 73, n. 7, p. 813-822, July 2002.
VASCONCELLOS, D. V.; DUARTE, M. E. L.; MAIA, R. C. Efeito antitumoral dos
bisfosfonatos: uma nova perspectiva terapêutica. Revista Brasileira de Cancerologia, Rio de
Janeiro, v. 50, n. 1, p. 45-54, 2004.
VASIKARAN, S. D. Bisphosphonates: an overview with special reference to alendronate.
Annals of Clinical Biochemistry, London, v. 38, n. 6, p. 608-623, Nov. 2001.
VEINSTEIN, R. S. et al. Promotion of osteoclast survival and antagonism of bisphosphonate-
induced osteoclast apoptosis by glucocorticoids. Journal of Clinical Investigation, Berlin, v.
109, n. 8, p. 1041-1048, Apr. 2002.